Swedish health department rejects patient fund demands
This article was originally published in Clinica
Executive Summary
Sweden's ruling Social Democratic Party has rejected calls from the opposition Christian Democratic Party leader Alf Svensson to introduce a patient supplementary payment fund to boost the health service. Social insurance minister Ingela Thalen acknowledges that that more money must be injected into the system, and says that this must rise to 10% of the GDP compared with the present level of nearly 8%. This would mean a total of SKr25-30 billion ($2.4-2.9 billion) per year. During the past few years, the government has introduced a plan to tackle the deficit and a programme to make the health service more accessible at a cost of some SKr13 billion.
You may also be interested in...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.